Further delineation of the molecular mechanisms underlying the effects of PTEN and AKT/p53 signaling on the differential modulation of tumor cell metabolism may improve the understanding of the link between genetic alterations and cellular metabolism in cancer and contribute to more effective and less toxic treatments. This evidence concerns the gene AKT1 and cancer.